Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity – MedCity News

Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity  MedCity News

This ‘switch’ could put an end to your weight loss plateaus, say scientists – BBC Science Focus

This ‘switch’ could put an end to your weight loss plateaus, say scientists  BBC Science Focus

Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life – Clinical Trials Arena

Asceletis’ muscle-preserving weight loss therapy sustains 40-day half-life  Clinical Trials Arena

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal – The Wall Street Journal

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal  The Wall Street Journal

Ono earmarks $940m to gain rare blood cancer therapy from Ionis

Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy by Ionis to treat…

Roche broadens obesity drug plans with $1.65B Zealand deal – BioPharma Dive

Roche broadens obesity drug plans with $1.65B Zealand deal  BioPharma Dive

Ending of US weight-loss drug shortages prompts compounder complaints – Chemistry World

Ending of US weight-loss drug shortages prompts compounder complaints  Chemistry World

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery – HealthDay

No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery  HealthDay

Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications – Medical Xpress

Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications  Medical Xpress

Envirotainer expands cold chain solutions portfolio to cover all pharma segments, sizes and temperatures

The specialist in temperature-sensitive pharmaceutical shipments, is introducing the industry’s most comprehensive cold chain portfolio.